CSIMarket
 
Acro Biomedical Co Ltd   (ACBM)
Other Ticker:  
 
    Sector  Services    Industry Movies and Entertainment
   Industry Movies and Entertainment
   Sector  Services
 
Price: $0.1050 $0.00 0.000%
Day's High: $0.105 Week Perf: -86 %
Day's Low: $ 0.11 30 Day Perf: -96.86 %
Volume (M): 0 52 Wk High: $ 4.25
Volume (M$): $ 0 52 Wk Avg: $2.42
Open: $0.11 52 Wk Low: $0.11



 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 60
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Acro Biomedical Co Ltd
Acro Biomedical Co Ltd is a biotechnology company that specializes in developing and commercializing medical products. The company focuses on research and development in the field of regenerative medicine and biopharmaceuticals. Acro Biomedical aims to provide innovative solutions to improve patient outcomes and enhance the quality of life. The company is committed to leveraging advanced technologies and scientific expertise to address unmet medical needs. Acro Biomedical Co Ltd is dedicated to making a positive impact on healthcare by delivering safe and effective medical products.


   Company Address: 12175 Visionary Way Fishers 46038 IN
   Company Phone Number: 286-6788   Stock Exchange / Ticker: ACBM
   ACBM is expected to report next financial results on July 20, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Acro Biomedical Co Ltd

Acro Biomedical Co Ltd Delivers Positive Financial Results, Highlighting Significant Improvement in Operating Loss


Introduction
Acro Biomedical Co Ltd, a well-known Movies and Entertainment company, has recently announced its financial results for the April to June 2023 reporting season. The company's top-line adjustments were not initially considered by investors; however, what caught their attention was the significant improvement in the operating loss. This article aims to examine the positive developments and the impact they may have on the company's future prospects.
Operating Loss and Market Observers Affirmation
During the reported period of April to June 2023, Acro Biomedical Co Ltd experienced an operating loss of $3.1947 million. Although this may seem like negative news at first glance, it is important to note the improvement from the previous year's corresponding quarter, which recorded an operating loss of $3.996432 million. This decrease in the operating loss has provided market observers with affirmation regarding the company's progress.

Acro Biomedical Co Ltd

ACBM Holds Steady: Revenues Mirror Last Fiscal Year Despite Mounting Challenges



Acro Biomedical Co Ltd, a company operating in an undisclosed industry, recently released its financial results for the most recent fiscal period. The results indicate a concerning increase in loss per share compared to the previous year, a decline in revenue, and a larger net shortfall. This article aims to interpret these financial figures and explore the potential impact they may have on Acro Biomedical Co Ltd's future.
1. Increased Shortfall per Share:
Acro Biomedical Co Ltd experienced a significant increase in shortfall per share, standing at $-0.07 compared to $0.00 from the previous year. This indicates that the company's expenses have exceeded its revenue, which could raise concerns among investors and stakeholders. The consecutive shortfall increase from the prior financial reporting period could also suggest potential financial instability.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com